Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00324961
Status:
COMPLETED
Last Update Posted:
2009-10-28
First Post:
2006-05-09
Brief Title:
Adefovir Dipivoxil Tablets 10mg In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A 2-year Multi-centre Open-label Local Phase IV Study to Demonstrate the Efficacy and Safety of Adefovir Dipivoxil Tablets 10mg in Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
Status:
COMPLETED
Status Verified Date:
2009-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a phase IV 2-year multi-center single arm and open-label study evaluating the efficacy and safety with using local manufactured adefovir dipivoxil in Chinese subjects with HBeAg negative chronic hepatitis B
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None